{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:46:30Z","timestamp":1769877990323,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,2,6]]},"DOI":"10.1038\/bjc.2017.404","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T21:00:56Z","timestamp":1510693256000},"page":"416-420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells"],"prefix":"10.1038","volume":"118","author":[{"given":"Peng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"BFbjc2017404_CR1","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/pros.21323","volume":"71","author":"AM Canacci","year":"2011","unstructured":"Canacci AM, Izumi K, Zheng Y, Gordetsky J, Yao JL, Miyamoto H (2011) Expression of semenogelins I and II and its prognostic significance in human prostate cancer. Prostate 71: 1108\u20131114.","journal-title":"Prostate"},{"key":"BFbjc2017404_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-4598-5-17","volume":"5","author":"LC Costello","year":"2006","unstructured":"Costello LC, Franklin RB (2006) The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 5: 17.","journal-title":"Mol Cancer"},{"key":"BFbjc2017404_CR3","doi-asserted-by":"publisher","first-page":"T179","DOI":"10.1530\/ERC-16-0422","volume":"23","author":"I Coutinho","year":"2016","unstructured":"Coutinho I, Day TK, Tilley WD, Selth LA (2016) Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence. Endocr Relat Cancer 23: T179\u2013T197.","journal-title":"Endocr Relat Cancer"},{"key":"BFbjc2017404_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/42750","volume":"387","author":"DM Heery","year":"1997","unstructured":"Heery DM, Kalkhoven E, Hoare S, Parker MG (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptor. Nature 387: 733\u2013736.","journal-title":"Nature"},{"key":"BFbjc2017404_CR5","first-page":"738","volume":"5","author":"H Ishiguro","year":"2015","unstructured":"Ishiguro H, Izumi K, Kashiwagi E, Zheng Y, Li Y, Kawahara T, Miyamoto H (2015) Semenogelin I promotes prostate cancer growth via functioning as an androgen receptor coactivator and protecting against zinc cytotoxicity. Am J Cancer Res 5: 738\u2013747.","journal-title":"Am J Cancer Res"},{"key":"BFbjc2017404_CR6","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.humpath.2012.02.008","volume":"43","author":"K Izumi","year":"2012","unstructured":"Izumi K, Li Y, Zheng Y, Gordetsky J, Yao JL, Miyamoto H (2012) Seminal plasma proteins in prostatic carcinoma: increased nuclear semenogelin I expression is a predictor of biochemical recurrence after radical prostatectomy. Hum Pathol 43: 1991\u20132000.","journal-title":"Hum Pathol"},{"key":"BFbjc2017404_CR7","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1007\/s00018-006-6287-0","volume":"63","author":"M Jonsson","year":"2006","unstructured":"Jonsson M, Lundwall \u00c5, Malm J (2006) The semenogelins: proteins with functions beyond reproduction? Cell Mol Life Sci 63: 2886\u20132888.","journal-title":"Cell Mol Life Sci"},{"key":"BFbjc2017404_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1517\/17425247.2016.1125879","volume":"13","author":"K Kurrikoff","year":"2016","unstructured":"Kurrikoff K, Gestin M, Langel \u00dc (2016) Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. Expert Opin Drug Deliv 13: 373\u2013387.","journal-title":"Expert Opin Drug Deliv"},{"key":"BFbjc2017404_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/(SICI)1097-0045(19990801)40:3<200::AID-PROS8>3.0.CO;2-3","volume":"40","author":"JY Liang","year":"1999","unstructured":"Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P (1999) Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 40: 200\u2013207.","journal-title":"Prostate"},{"key":"BFbjc2017404_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1172\/JCI113070","volume":"80","author":"H Lilja","year":"1987","unstructured":"Lilja H, Oldbring J, Rannevik G, Laurell CB (1987) Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 80: 281\u2013285.","journal-title":"J Clin Invest"},{"key":"BFbjc2017404_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/ijc.21217","volume":"117","author":"H Miyamoto","year":"2005","unstructured":"Miyamoto H, Marwah P, Marwah A, Yang Z, Chung C-Y, Altuwaijri S, Chang C, Lardy H (2005) Identification of steroid derivatives that function as potent antiandrogens. Int J Cancer 117: 866\u2013872.","journal-title":"Int J Cancer"},{"key":"BFbjc2017404_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65: 87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"BFbjc2017404_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1006\/bbrc.2000.3975","volume":"279","author":"G Untergasser","year":"2000","unstructured":"Untergasser G, Rumpold H, Plas E, Witkowski M, Pfister G, Berger P (2000) High levels of zinc ions induce loss of mitochondrial potential and degradation of antiapoptotic Bcl-2 protein in in vitro cultivated human prostate epithelial cells. Biochem Biophys Res Commun 279: 607\u2013614.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFbjc2017404_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mce.2011.08.007","volume":"352","author":"DJ van de Wijngaart","year":"2012","unstructured":"van de Wijngaart DJ, Dubbink HJ, van Royen ME, Trapman J, Jenster G (2012) Androgen receptor coregulators: recruitment via the coactivator binding groove. Mol Cell Endocrinol 352: 57\u201369.","journal-title":"Mol Cell Endocrinol"},{"key":"BFbjc2017404_CR15","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1210\/me.2015-1128","volume":"29","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Ishiguro H, Ide H, Inoue S, Kashiwagi E, Kawahara T, Jalalizadeh M, Reis LO, Miyamoto H (2015) Compound A inhibits bladder cancer growth predominantly via glucocorticoid receptor transrepression. Mol Endocrinol 29: 1486\u20131497.","journal-title":"Mol Endocrinol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2017404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017404","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:40:24Z","timestamp":1684417224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2017404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2,6]]}},"alternative-id":["BFbjc2017404"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.404","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"assertion":[{"value":"8 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}